Human Endokine Alpha

Details for Australian Patent Application No. 2007202630 (hide)

Owner Human Genome Sciences, Inc.

Inventors Ni, Juan; Rosen, Craig A; Yu, Guo-Liang

Agent Wrays

Pub. Number AU-B-2007202630

Parent 2003257892

Filing date 8 June 2007

Wipo publication date 28 June 2007

Acceptance publication date 22 April 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

28 June 2007 Application Open to Public Inspection

  Published as AU-B-2007202630

28 June 2007 Complete Application Filed

22 April 2010 Application Accepted

  Published as AU-B-2007202630

19 August 2010 Standard Patent Sealed

19 August 2010 Corrigenda

  Applications Accepted - Name Index Under the name Human Genome Sciences, Inc., Application No. 2007202630, under INID (72) correct the coinventor to Ni, Jian

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202631-System and Method for Use of Multiple Applications

2007202629-Nasal-administered vaccines